Saturday, July 19, 2025
Blogger Facebook Linkedin Pinterest Twitter Youtube

Tag: clinical development

Sun Pharma and Israel-based Moebius Medical have announced that the US Food and Drug Administration (FDA) has granted fast-frack designation (FTD) to MM-II (large liposomes of DPPC and DMPC) for the treatment of osteoarthritis knee pain.

FDA go-ahead to Sun Pharma to develop osteoarthritis knee pain drug

HTP Desk - 0
Sun Pharma and Israel-based Moebius Medical have announced that the US Food and Drug Administration (FDA) has granted fast-frack designation (FTD) to MM-II (large...
Healthtekpak delivers daily news, updates, analysis, case studies and industry scoops related to the health industry.
Contact us: editor@ippgroup.in
Blogger Facebook Linkedin Pinterest Twitter Youtube
© 2024 All content (text and/or media) is intellectual property of IPP Catalog Publications Pvt. Ltd.

This function has been disabled for HealthTekPak.

error: Content is protected !!